Momenta, Sandoz Push For Sanctions In Blood Clot Drug Suit

By Adam Lidgett · September 16, 2019, 5:30 PM EDT

Momenta and Sandoz have urged a Tennessee federal court to sanction a hospital accusing them of conspiring to monopolize the blood clot drug Lovenox and its generic version for allegedly not properly...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

The Hospital Authority of Metropolitan Government of Nashville and Davidson County, Tennessee v. Momenta Pharmaceuticals, Inc. et al

Case Number

3:15-cv-01100

Court

Tennessee Middle

Nature of Suit

Anti-Trust

Date Filed

October 14, 2015